According to a STAT News report covered by Boing Boing, an unidentified seventy-nine-year-old patient has received Eli Lilly's experimental obesity drug retatrutide through the FDA's compassionate use program. The White House has declined to confirm the patient's identity, though the story has generated considerable speculation.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton